Psychiatry and Neurology, Neurology · Dallas, TX
NPI
1891180311
Since 2015
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
3
Medicare group memberships
Hospitals
3
Hospital affiliations
3417 Gaston Ave Ste 935
Dallas, TX, 75246
Phone (469) 800-7680
Groups this clinician bills Medicare through
Medicare paid, 2024
$269K
31,782 services
Medicare patients, 2024
426
Average age 75
Drug cost, 2024
$2.4M
3,130 prescriptions
Company payments, 2025
$7,540
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mazen T Elkurd was code J0585 (injection, onabotulinumtoxina, 1 unit), 15,030 times for 35 patients. In total Mazen T Elkurd billed 31,782 services in 36 codes, and Medicare paid $269K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-02-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 15,030 | 35 | $4.98 | $75K |
| J0588 Injection, incobotulinumtoxin a, 1 unit | Office | 9,690 | 17 | $4.09 | $40K |
| 99214 Office E&M - Established | Office | 341 | 222 | $86.55 | $30K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 315 | 224 | $12.79 | $4,028 |
| 99215 Office E&M - Established | Office | 120 | 108 | $133.68 | $16K |
| 95874 Musculoskeletal | Office | 114 | 49 | $59.27 | $6,756 |
| 64616 Musculoskeletal | Office | 88 | 37 | $143.27 | $13K |
| 99205 Office E&M - New | Office | 86 | 86 | $160.00 | $14K |
| 64646 Musculoskeletal | Office | 76 | 33 | $70.77 | $5,378 |
| 64612 Musculoskeletal | Office | 58 | 21 | $121.77 | $7,063 |
| 99213 Office E&M - Established | Office | 55 | 50 | $53.23 | $2,928 |
| 95984 Electrical Nerve Conductivity | Office | 37 | 11 | $26.96 | $998 |
| 11105 Skin Biopsy | Office | 36 | 18 | $46.72 | $1,682 |
| 95983 Electrical Nerve Conductivity | Office | 33 | 12 | $36.43 | $1,202 |
| 36415 Venipuncture Blood Collection | Office | 31 | 31 | $8.39 | $260 |
By year: 2022 $96K for 7,065 services; 2023 $227K for 23,554 services; 2024 $269K for 31,782 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 31 | 31 | $8.39 | $260 |
Medicare prescription drug claims, 2024
In 2024, the drug Mazen T Elkurd prescribed most often to Medicare patients was Rytary (Carbidopa/Levodopa), with 629 prescriptions and refills. In total Mazen T Elkurd wrote 3,130 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rytary Carbidopa/Levodopa | 629 | 1,279 | 149 | $888K |
| Carbidopa-Levodopa Carbidopa/Levodopa | 506 | 1,112 | 176 | $23K |
| Donepezil Hcl Generic | 147 | 291 | 38 | $1,299 |
| Gabapentin Generic | 121 | 209 | 32 | $2,032 |
| Nuplazid Pimavanserin Tartrate | 94 | 116 | 14 | $563K |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 90 | 240 | 32 | $7,948 |
| Clonazepam Generic | 72 | 130 | 28 | $803 |
| Propranolol Hcl Generic | 72 | 117 | 31 | $2,722 |
| Memantine Hcl Generic | 68 | 139 | 23 | $2,445 |
| Rasagiline Mesylate Generic | 67 | 168 | 22 | $12K |
| Quetiapine Fumarate Generic | 65 | 110 | 20 | $968 |
| Amantadine Amantadine Hcl | 64 | 152 | 25 | $2,815 |
| Entacapone Generic | 64 | 152 | 22 | $11K |
| Primidone Generic | 64 | 103 | 20 | $2,428 |
| Escitalopram Oxalate Generic | 63 | 120 | 22 | $602 |
Brand drugs: 1,050 claims; generic drugs: 2,080 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mazen T Elkurd $7,540 ($7,540 in general payments such as food, travel and fees) from 24 companies. The largest payer was Merz Pharmaceuticals, LLC with $4,505.
| Company | Payments | Amount |
|---|---|---|
| Merz Pharmaceuticals, LLC | 9 | $4,505 |
| Abbvie Inc. ABBV | 31 | $533 |
| UCB, Inc. UCB.BR | 16 | $433 |
| ACADIA Pharmaceuticals Inc ACAD | 17 | $301 |
| Teva Pharmaceuticals USA, Inc. TEVA | 6 | $241 |
| Argenx US, Inc. ARGX | 5 | $170 |
| MDD US Operations, LLC | 8 | $169 |
| Jazz Pharmaceuticals Inc. JAZZ | 5 | $163 |
| SK Life Science, Inc. | 5 | $120 |
| Neurocrine BioSciences, Inc. NBIX | 3 | $96.2 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.